RET C634R
|
Thyroid Gland Medullary Carcinoma
|
RET C634R
|
Thyroid Gland Medullary Carcinoma
|
sorafenib Sensitive: C3 – Early Trials
|
sorafenib Sensitive: C3 – Early Trials
|
RET C634R
|
Thyroid Gland Carcinoma
|
RET C634R
|
Thyroid Gland Carcinoma
|
XMD15-44 Sensitive: D – Preclinical
|
XMD15-44 Sensitive: D – Preclinical
|
RET C634R
|
Thyroid Gland Carcinoma
|
RET C634R
|
Thyroid Gland Carcinoma
|
HG-6-63-01 Sensitive: D – Preclinical
|
HG-6-63-01 Sensitive: D – Preclinical
|
RET C634R
|
Thyroid Gland Carcinoma
|
RET C634R
|
Thyroid Gland Carcinoma
|
ALW-II-41-27 Sensitive: D – Preclinical
|
ALW-II-41-27 Sensitive: D – Preclinical
|